SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-135559
Filing Date
2020-05-07
Accepted
2020-05-07 07:00:33
Documents
3
Period of Report
2020-05-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d926473d8k.htm 8-K 18246
2 EX-99.1 d926473dex991.htm EX-99.1 75999
3 GRAPHIC g926473g0506215429495.jpg GRAPHIC 5859
  Complete submission text file 0001193125-20-135559.txt   103657
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37465 | Film No.: 20854497
SIC: 2834 Pharmaceutical Preparations